Evidera
Zaira Escamilla is a dedicated professional in the field of research with a strong background in public health and medicine. Currently serving as a Research Associate at Evidera since January 2022, Zaira previously held positions as a Research Assistant at McMaster University, a Research Analyst at the University Health Network's Princess Margaret Cancer Centre, a Project Assistant at PPD, a Clinical Study Coordinator at Althian, and a Junior Research Assistant at Health Solutions. Zaira possesses a Master of Public Health degree from Western University and a Doctor of Medicine degree from Universidad Nacional Autónoma de México, with expertise in systematic reviews and economic evaluation of drugs.
This person is not in any offices
Evidera
1 followers
Evidera is a business within Pharmaceutical Product Development, LLC, (PPD) a leading global contract research organization (CRO), and is the preeminent provider of evidence-based solutions to demonstrate the real-world effectiveness, safety, and value of biopharmaceutical and biotechnology products from early development through loss of exclusivity. We provide integrated scientific expertise and global operational capabilities to help you generate the evidence needed to optimize the market access and commercial potential of your products. Evidera was acquired by PPD in 2016 and originally created in 2013 as an independent company under the ownership of Symphony Technology Group following the acquisition of long-standing health economics, outcomes research, market access, epidemiology, and data analytics practices from United BioSource Corporation (UBC). Evidera has over 30 years of leadership and experience and its legacy brands include MEDTAP, Caro Research, Abt Bio-Pharmaceutical Solutions, MetaWorks, Total Healthcare Group, and Archimedes.